Newport Beach, CALIFORNIA4 Active Studies

Interstitial Lung Disease Clinical Trials in Newport Beach, CALIFORNIA

Find 4 actively recruiting interstitial lung disease clinical trials in Newport Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,254
Enrolling

Recruiting Interstitial Lung Disease Studies in Newport Beach

RecruitingNewport Beach, CALIFORNIANCT06025578

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis....

1,092 participants
Bristol-Myers Squibb
View Study Details
RecruitingNewport Beach, CALIFORNIANCT05943535

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period....

698 participants
United Therapeutics
View Study Details
RecruitingNewport Beach, CALIFORNIANCT06329401

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants wit...

300 participants
Avalyn Pharma Inc.
View Study Details
RecruitingNewport Beach, CALIFORNIANCT06967805

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)...

164 participants
Mediar Therapeutics
View Study Details

About Interstitial Lung Disease Clinical Trials in Newport Beach

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 4 interstitial lung disease clinical trials recruiting participants in Newport Beach, CALIFORNIA. These studies are seeking a combined 2,254 participants. Research is being sponsored by Bristol-Myers Squibb, United Therapeutics, Avalyn Pharma Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Newport Beach — FAQ

Are there interstitial lung disease clinical trials in Newport Beach?

Yes, there are 4 interstitial lung disease clinical trials currently recruiting in Newport Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 4 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated March 2, 2026 from ClinicalTrials.gov